EUROPEAN NEUROPSYCHOPHARMACOLOGY Q1区

期刊简介

European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.

欧洲神经精神药理学是欧洲神经精神药理学学会（ECNP）的官方出版物。根据学院的使命，该杂志侧重于临床和基础科学的贡献，促进我们对大脑功能和人类行为的理解，并使之能够转化为精神病学的改进治疗和增强公共卫生影响。近年来，神经科学和基因组学的基础知识和可用的实验技术取得了令人兴奋的进展。然而，这些发现的临床转化并不迅速。该杂志旨在通过推广预期将对我们理解精神障碍的生物学基础以及治疗方法的开发和改进产生重大影响的发现来缩小这一差距，理想地为预防和康复铺平道路。

《EUROPEAN NEUROPSYCHOPHARMACOLOGY》期刊已被查看： 次

期刊官网投稿信息

分区信息

• 上一篇： FULLERENES NANOTUBES AND CARBON NANOSTRUCTURES
• 下一篇：FOOD AND CHEMICAL TOXICOLOGY